Robert W. Coatney - Concepedia

Author

Robert W. Coatney

Also Known As

R. Coatney, R. W. Coatney, R. W. Cootney, R.W Coatney, R.W. Coatney, Robert Coatney, Robert W Coatney, Robert W. Coatney, S Chandra

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United States)GlaxoSmithKline (United Kingdom)New Frontier Purdue University West Lafayette Michigan State University

About

Robert W. Coatney is an author at GlaxoSmithKline (United States) specializing in medicine, physiology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	1.6K
2	Health Sciences	3	3	164
3	Education	2	2	80
4	Public Health	2	2	35
5	Anatomy	2	2	70

Robert W. Coatney

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 Robert S. Ames, Henry M. Sarau, Johathan K. Chambers, Nature Molecular PharmacologyUrologyG Protein-coupled ReceptorMedicineOrphan Receptor Gpr14	1999	788
Hypertensive End-Organ Damage and Premature Mortality Are p38 Mitogen-Activated Protein Kinase–Dependent in a Rat Model of Cardiac Hypertrophy and Dysfunction Thomas M. Behr, Sandhya S. Nerurkar, Allen H. Nelson, Circulation	2001	118
Applications of micro-CT and MR microscopy to study pre-clinical models of osteoporosis and osteoarthritis Rasesh Kapadia, George B. Stroup, Alison M. Badger, Technology and Health Care MicroscopyPre-clinical ModelsBiomedical EngineeringOsteoporosisOrthopaedic Surgery	1998	116
Monocyte Chemoattractant Protein-1 is Upregulated in Rats With Volume-Overload Congestive Heart Failure Thomas M. Behr, Xinkang Wang, Nambi Aiyar, Circulation	2000	116
Effects of p38 MAPK Inhibitor on Angiotensin II-Dependent Hypertension, Organ Damage, and Superoxide Anion Production Weike Bao, David J. Behm, Sandhya S. Nerurkar, Journal of Cardiovascular Pharmacology HypertensionCardiovascular PharmacologyP38 MapkPharmacotherapyAng Ii	2007	98
GW427353 (Solabegron), a Novel, Selective β3-Adrenergic Receptor Agonist, Evokes Bladder Relaxation and Increases Micturition Reflex Threshold in the Dog Alexandra Hicks, Gerald P. McCafferty, Erin S. Riedel, Journal of Pharmacology and Experimental Therapeutics	2007	91
Differences in Effects on Myocardium and Mitochondria by Angiogenic Inhibitors Suggest Separate Mechanisms of Cardiotoxicity Kevin J. French, Robert W. Coatney, Jon Renninger, Toxicologic Pathology Cardiac MuscleCardiovascular PharmacologyPharmacotherapyCardiovascular ToxicityRat Model	2010	71
Deletion of the UT receptor gene results in the selective loss of urotensin‐II contractile activity in aortae isolated from UT receptor knockout mice David J. Behm, Stephen Harrison, Zhaohui Ao, British Journal of Pharmacology HypertensionHeart FailureCardiovascular PharmacologyUrotensin‐ii Contractile ActivityCardiovascular Function	2003	65
Gastric pH and Gastric Residence Time in Fasted and Fed Conscious Beagle Dogs using the Bravo® pH System Kelly M. Mahar, Samm Portelli, Robert W. Coatney, Journal of Pharmaceutical Sciences Animal PhysiologyVeterinary PhysiologyGastric PhAnimal NutritionAnimal Science	2012	60
Comparison of Soluble Guanylate Cyclase Stimulators and Activators in Models of Cardiovascular Disease Associated with Oxidative Stress Melissa H. Costell, Nicolas Ancellin, Roberta E. Bernard, Frontiers in Pharmacology HypertensionHeart FailureCardiovascular DiseaseBiochemistryNitric Oxide	2012	59

Page 1